Market Overview

Benzinga's Top Downgrades

Related CPHD
Cepheid Posts Narrower-than-Expected Q2 Loss, Revenues Rise
Cepheid Forms Pharma Alliance to Fight Antibiotic Resistance - Analyst Blog
Related ABT
Markets Sell-Off After Malaysian Airline Crash In Ukraine
UPDATE: Morgan Stanley Reiterates On Abbott Laboratories As Growth and Margins Are Set To Continue
Will Congress Scuttle the AbbVie-Shire Merger? (Fox Business)

Analysts at Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from “overweight” to “neutral.” Cepheid's shares closed at $34.09 yesterday. Cepheid's trailing-twelve-month ROE is -12.52%.

Analysts at Deutsche Bank downgraded Abbott Laboratories (NYSE: ABT) from “buy” to “hold.” Abbott's shares closed at $33.27 yesterday. Abbott's PEG ratio is 0.51.

Analysts at Goldman Sachs downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” Wells Fargo's shares closed at $34.76 yesterday. Wells Fargo's trailing-twelve-month profit margin is 23.18%.

Raymond James downgraded First Solar (NASDAQ: FSLR) from “market perform” to “underperform.” First Solar's shares closed at $34.41 yesterday. First Solar's trailing-twelve-month ROA is 2.17%.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (CPHD + ABT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters